Bio-Path Holdings Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2020 - 2016
Selling, General & Admin	2.03	4.7	4.24	4.74	4.53	Upgrade
Research & Development	6.3	7.3	11.61	9.17	5.91	Upgrade
Operating Expenses	8.33	11.99	15.84	13.9	10.44	Upgrade
Operating Income	-8.33	-11.99	-15.84	-13.9	-10.44	Upgrade
Interest Expense	-0.21	-	-	-	-	Upgrade
Interest & Investment Income	-	0.01	0.04	0.03	0	Upgrade
Other Non Operating Income (Expenses)	-0.13	2.08	-0.27	-	-	Upgrade
EBT Excluding Unusual Items	-8.67	-9.89	-16.08	-13.87	-10.44	Upgrade
Pretax Income	-8.67	-9.89	-16.08	-13.87	-10.44	Upgrade
Net Income	-8.67	-9.89	-16.08	-13.87	-10.44	Upgrade
Net Income to Common	-8.67	-9.89	-16.08	-13.87	-10.44	Upgrade
Shares Outstanding (Basic)	8	2	0	0	0	Upgrade
Shares Outstanding (Diluted)	8	2	0	0	0	Upgrade
Shares Change (YoY)	229.28%	402.30%	31.32%	8.25%	74.81%	Upgrade
EPS (Basic)	-1.10	-4.12	-33.64	-38.10	-31.05	Upgrade
EPS (Diluted)	-1.10	-4.12	-33.64	-38.12	-31.05	Upgrade
Free Cash Flow	-1.6	-10.58	-11.54	-15.12	-9.99	Upgrade
Free Cash Flow Per Share	-0.20	-4.40	-24.13	-41.55	-29.70	Upgrade
EBITDA	-8.31	-11.94	-15.76	-13.81	-10.37	Upgrade
D&A For EBITDA	0.02	0.05	0.08	0.09	0.08	Upgrade
EBIT	-8.33	-11.99	-15.84	-13.9	-10.44	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.